Quarterly EBITDA
-$1.19 M
+$661.00 K+35.65%
September 30, 2022
Summary
- As of February 10, 2025, REVBU quarterly EBITDA is -$1.19 million, with the most recent change of +$661.00 thousand (+35.65%) on September 30, 2022.
- Over the past year, REVBU quarterly EBITDA has increased by +$1.84 million (+60.72%).
Performance
REVBU Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$9.63 M
+$1.84 M+16.08%
September 30, 2022
Summary
- As of February 10, 2025, REVBU TTM EBITDA is -$9.63 million, with the most recent change of +$1.84 million (+16.08%) on September 30, 2022.
- Over the past year, REVBU TTM EBITDA has dropped by -$1.54 million (-19.11%).
Performance
REVBU TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
REVBU EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +60.7% | -19.1% |
| 3 y3 years | - | +54.2% | -269.3% |
| 5 y5 years | - | +54.2% | -269.3% |
REVBU EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +451.5% | +19.1% | +25.2% | ||
| 5 y | 5-year | at high | +451.5% | +269.3% | +25.2% | ||
| alltime | all time | at high | +451.5% | +269.3% | +25.2% |
Revelation Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$1.19 M(-35.6%) | -$9.63 M(-16.1%) |
| Jun 2022 | - | -$1.85 M(-71.8%) | -$11.47 M(-4.8%) |
| Mar 2022 | - | -$6.58 M(+116.6%) | -$12.06 M(+49.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$3.04 M(+24.6%) | -$8.08 M(+60.2%) |
| Jun 2021 | - | -$2.44 M(-6.5%) | -$5.05 M(+93.5%) |
| Mar 2021 | - | -$2.61 M | -$2.61 M |
FAQ
- What is Revelation Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Revelation Biosciences?
- What is Revelation Biosciences quarterly EBITDA year-on-year change?
- What is Revelation Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Revelation Biosciences?
- What is Revelation Biosciences TTM EBITDA year-on-year change?
What is Revelation Biosciences quarterly EBITDA?
The current quarterly EBITDA of REVBU is -$1.19 M
What is the all time high quarterly EBITDA for Revelation Biosciences?
Revelation Biosciences all-time high quarterly EBITDA is -$1.19 M
What is Revelation Biosciences quarterly EBITDA year-on-year change?
Over the past year, REVBU quarterly EBITDA has changed by +$1.84 M (+60.72%)
What is Revelation Biosciences TTM EBITDA?
The current TTM EBITDA of REVBU is -$9.63 M
What is the all time high TTM EBITDA for Revelation Biosciences?
Revelation Biosciences all-time high TTM EBITDA is -$2.61 M
What is Revelation Biosciences TTM EBITDA year-on-year change?
Over the past year, REVBU TTM EBITDA has changed by -$1.54 M (-19.11%)